Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599040 · ClinicalTrials.gov registry record · Phase 4
The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 113
- Enrollment target
NCT00599040 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 113 participants.
The verdict
NCT00599040, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 113 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if what you eat affets your insulin sensitivity when you lose a small amount of weight
Interventions
- BEHAVIORAL The DASH diet with weight loss
- BEHAVIORAL The DASH diet without weight loss
- BEHAVIORAL Dairy diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2005-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00599040
The ClinicalTrials.gov registry entry for NCT00599040 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which The DASH diet with weight loss is the first listed.
NCT00599040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00599040 about?
NCT00599040 is a clinical study titled "The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)". The purpose of this study is to determine if what you eat affets your insulin sensitivity when you lose a small amount of weight
What is the current status of trial NCT00599040?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 113 participants. The study started on 2005-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00599040?
The interventions under investigation include: The DASH diet with weight loss (BEHAVIORAL), The DASH diet without weight loss (BEHAVIORAL), Dairy diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00599040?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.